ADVERTISEMENT
China’s Biotech Investors Have Caught a Chill
Even Chinese investors without government backing have felt a chill since the arrest of Huawei’s Meng Wanzhou in December.
05 Mar 2019, 04:07 PM IST
(Bloomberg Businessweek) -- Four years ago, President Xi Jinping’s government rolled out the Made in China 2025 strategy to dominate the global economy with its homegrown technology. Chinese government-backed venture capital firms that still wanted to buy U.S. assets identified health care as a sector they could invest in without running afoul of regulators at home.
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Free
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT